Profile data is unavailable for this security.
About the company
Fermentalg SA is a France-based industrial biotechnology company. It specializes in the development of a technology which is used to produce molecules of interest and bypasses conventional methods using petrochemicals and also industrial fish farming. The Company offers a solution to the gradual depletion of two key resources: wild fish and petroleum. The Company's technology allows it to target a range of markets, such as human nutrition, animal feed, green chemicals, cosmetics and biofuels.
- Revenue in EUR (TTM)4.06m
- Net income in EUR-14.15m
- Incorporated2009
- Employees62.00
- LocationFermentalg SA4 Rue RiviereLIBOURNE 33500FranceFRA
- Phone+33 557250220
- Websitehttps://www.fermentalg.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valerio Therapeutics SA | 1.80m | -20.34m | 17.44m | 19.00 | -- | 1.18 | -- | 9.69 | -0.1566 | -0.1566 | 0.0133 | 0.0961 | 0.0459 | -- | 1.07 | 94,736.84 | -51.92 | -34.19 | -67.72 | -40.59 | 70.39 | 84.11 | -1,130.22 | -586.99 | -- | -171.66 | 0.3776 | -- | 24.74 | -21.73 | -4.00 | -- | 32.39 | -- |
| Phaxiam Therapeutics SA | 1.33m | -23.49m | 17.95m | 51.00 | -- | 0.7009 | -- | 13.54 | -5.56 | -5.56 | 0.3139 | 4.22 | 0.0273 | -- | 14.82 | 26,000.00 | -48.37 | -50.69 | -66.94 | -66.25 | -- | -- | -1,771.42 | -1,009.09 | -- | -70.21 | 0.3412 | -- | -80.05 | -21.50 | -10,201.75 | -- | -56.68 | -- |
| SMAIO SA | 7.62m | 1.06m | 19.87m | 37.00 | 18.65 | 1.83 | 8.35 | 2.61 | 0.2038 | 0.2038 | 1.46 | 2.07 | 0.5624 | 0.1871 | 17.23 | 206,027.60 | 7.81 | -7.87 | 10.24 | -19.76 | 96.95 | 96.04 | 13.89 | -22.48 | 2.54 | 11.07 | 0.1991 | -- | 212.18 | 114.99 | -62.80 | -- | -- | -- |
| Oncodesign Precision Medicine Opm SA | 1.07m | -8.09m | 22.28m | 22.00 | -- | 5.52 | -- | 20.78 | -0.4863 | -0.4863 | 0.0645 | 0.2219 | 0.0613 | -- | 1.39 | 48,735.00 | -46.23 | -- | -63.87 | -- | 130.48 | -- | -754.61 | -- | -- | -- | 0.7052 | -- | -86.57 | -- | -3,399.73 | -- | -- | -- |
| Predilife SA | 317.79k | -4.22m | 23.44m | 19.00 | -- | -- | -- | 73.75 | -1.14 | -1.14 | 0.0858 | -1.06 | 0.0695 | -- | 2.05 | 17,030.55 | -92.43 | -89.36 | -129.39 | -123.81 | 97.25 | 83.94 | -1,329.21 | -1,901.22 | -- | -6.23 | 2.20 | -- | 10.11 | 79.85 | -15.58 | -- | -18.51 | -- |
| Nfl Biosciences SAS | 0.00 | -3.48m | 23.44m | 3.00 | -- | 5.89 | -- | -- | -0.5396 | -0.5396 | 0.00 | 0.4097 | 0.00 | -- | -- | 0.00 | -80.79 | -- | -125.59 | -- | -- | -- | -- | -- | -- | -- | 0.0228 | -- | -- | -- | -149.78 | -- | -- | -- |
| Advicenne SA | 2.94m | -7.03m | 29.70m | 20.00 | -- | -- | -- | 10.10 | -0.6728 | -0.6728 | 0.2805 | -0.9746 | 0.2207 | 4.41 | 2.22 | 147,100.00 | -52.73 | -57.86 | -129.08 | -89.10 | -104.21 | -327.56 | -238.99 | -513.56 | 0.9196 | -18.36 | 3.19 | -- | 25.67 | 25.03 | 38.70 | -- | 55.28 | -- |
| Fermentalg SA | 4.06m | -14.15m | 30.27m | 62.00 | -- | 0.9283 | -- | 7.46 | -0.3176 | -0.3176 | 0.0917 | 0.6033 | 0.0753 | 0.533 | 3.35 | 65,451.61 | -24.63 | -21.94 | -26.79 | -24.71 | 13.21 | 14.73 | -327.08 | -248.95 | 3.53 | -60.94 | 0.3323 | -- | -46.94 | 75.18 | -43.29 | -- | -10.93 | -- |
| Poxel SA | 1.55m | -44.24m | 31.25m | 30.00 | -- | -- | -- | 20.21 | -1.44 | -1.44 | 0.0507 | -1.22 | 0.0597 | -- | 5.42 | 30,920.00 | -170.71 | -31.97 | -432.50 | -55.94 | 0.1294 | -- | -2,861.58 | -101.47 | -- | -4.08 | 11.28 | -- | -94.97 | -33.77 | -32.13 | -- | -8.49 | -- |
| Valbiotis SA | 4.73m | -7.37m | 34.12m | 52.00 | -- | 1.74 | -- | 7.21 | -0.5904 | -0.5904 | 0.3798 | 1.24 | 0.1564 | 3.36 | 17.83 | 91,019.23 | -24.35 | -32.92 | -33.77 | -46.36 | 48.76 | 53.15 | -155.67 | -418.87 | 3.38 | -38.19 | 0.2598 | -- | 502.93 | 126.73 | 40.16 | -- | -21.71 | -- |
| Global Bioenergies SA | 3.25m | -8.66m | 36.37m | 46.00 | -- | 3.49 | -- | 11.19 | -0.4797 | -0.4797 | 0.1802 | 0.5743 | 0.1632 | 5.21 | 65.62 | 70,638.05 | -43.47 | -43.66 | -64.54 | -82.47 | -153.20 | -948.35 | -266.41 | -1,331.36 | 3.54 | -- | 0.2626 | -- | 365.83 | 36.25 | 27.78 | -- | -19.49 | -- |
| Gensight Biologics SA | 1.27m | -26.22m | 38.61m | 16.00 | -- | -- | -- | 30.47 | -0.5427 | -0.5427 | 0.0269 | -0.4726 | 0.0723 | -- | 2,534.00 | 79,187.50 | -149.52 | -79.44 | -- | -144.54 | -- | -- | -2,069.53 | -1,036.27 | -- | -- | -- | -- | -50.93 | -- | 5.09 | -- | -58.28 | -- |
| Abionyx Pharma SA | 4.64m | -3.52m | 40.12m | 61.00 | -- | 5.02 | -- | 8.65 | -0.121 | -0.121 | 0.1581 | 0.246 | 0.3027 | 21.86 | 4.20 | 76,694.22 | -22.95 | -18.82 | -32.52 | -28.87 | 13.32 | 14.32 | -75.82 | -128.54 | 1.70 | -- | 0.2997 | -- | -11.65 | 92.84 | 16.36 | -- | 41.40 | -- |
| Biosynex SA | 93.05m | -13.79m | 40.61m | 560.00 | -- | -- | -- | 0.4364 | -1.94 | -1.94 | -- | -- | -- | -- | -- | 248,141.30 | -- | 25.60 | -- | 33.90 | 25.22 | 51.82 | -13.15 | 20.26 | -- | -4.45 | -- | 14.72 | -48.61 | 45.12 | -84.99 | 118.26 | -- | -- |
| genOway SA | 18.63m | 1.59m | 40.81m | 124.00 | 24.26 | 2.39 | 10.17 | 2.19 | 0.1814 | 0.1814 | 2.12 | 1.84 | 0.5813 | 0.3881 | 2.50 | 142,180.80 | 4.98 | -0.5615 | 6.72 | -0.8058 | 97.61 | 93.72 | 8.56 | -1.12 | 2.10 | 17.42 | 0.3344 | -- | 21.64 | 11.57 | 341.09 | -16.63 | -18.02 | -- |
| Groupe Berkem SA | 51.94m | 367.00k | 41.40m | 200.00 | 112.83 | 1.48 | 9.31 | 0.797 | 0.0207 | 0.0207 | 2.92 | 1.57 | -- | -- | -- | 259,720.00 | -- | -- | -- | -- | 55.32 | -- | 0.7065 | -- | 0.8988 | 1.36 | 0.5798 | -- | 0.733 | -- | 123.42 | -- | -- | -- |
Data as of Jun 07 2024. Currency figures normalised to Fermentalg SA's reporting currency: Euro EUR
6.63%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Moneta Asset Management SASas of 27 Oct 2023 | 2.39m | 4.42% |
| OFI Invest Asset Management SAas of 31 Aug 2023 | 400.00k | 0.74% |
| AXA Investment Managers (Paris) SAas of 30 Apr 2024 | 315.00k | 0.58% |
| HSBC Global Asset Management (France) SAas of 30 Apr 2024 | 243.39k | 0.45% |
| FPM Frankfurt Performance Management AGas of 28 Mar 2024 | 100.00k | 0.19% |
| Chaussier Gestion SAas of 28 Mar 2024 | 70.00k | 0.13% |
| Gestys SAas of 26 Jan 2024 | 35.00k | 0.07% |
| Friedland Gestion SASas of 26 Jan 2024 | 19.90k | 0.04% |
| BlackRock Investment Management (UK) Ltd.as of 31 Jan 2022 | 6.94k | 0.01% |
| Claresco Finance SAas of 30 Jun 2023 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
